{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T20:00:33Z","timestamp":1785528033507,"version":"3.56.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Yttrium Little Red Flower Health Fund Project of Sunshine Medical and Health Development Foundation in Henan Province, China","award":["No. HKP2024002"],"award-info":[{"award-number":["No. HKP2024002"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.82202225"],"award-info":[{"award-number":["No.82202225"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00259-026-07919-x","type":"journal-article","created":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T06:49:11Z","timestamp":1779518951000},"page":"5853-5867","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The value of 18F-FAPI-04 PET\/CT in the assessment of unresectable hepatocellular carcinoma after selective internal radiation therapy: a preliminary exploratory study"],"prefix":"10.1007","volume":"53","author":[{"given":"Huanyu","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhilong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangshou","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjie","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qijun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengzhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingrong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6199-3929","authenticated-orcid":false,"given":"Hao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,23]]},"reference":[{"issue":"10360","key":"7919_CR1","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","volume":"400","author":"A Vogel","year":"2022","unstructured":"Vogel A, Meyer T, Sapisochin G, Salem R, Saborowski A. Hepatocellular carcinoma. Lancet. 2022;400(10360):1345\u201362. https:\/\/doi.org\/10.1016\/S0140-6736(22)01200-4.","journal-title":"Lancet"},{"issue":"11","key":"7919_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011313.pub4","volume":"11","author":"O Abdel-Rahman","year":"2020","unstructured":"Abdel-Rahman O, Elsayed Z. Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma. Cochrane Database Syst Rev. 2020;11(11):CD011313. https:\/\/doi.org\/10.1002\/14651858.CD011313.pub4.","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"7919_CR3","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3322\/caac.70018","volume":"75","author":"D Moris","year":"2025","unstructured":"Moris D, Martinino A, Schiltz S, Allen PJ, Barbas A, Sudan D, et al. Advances in the treatment of hepatocellular carcinoma: an overview of the current and evolving therapeutic landscape for clinicians. CA Cancer J Clin. 2025;75(6):498\u2013527. https:\/\/doi.org\/10.3322\/caac.70018.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"7919_CR4","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1148\/radiol.2018181494","volume":"289","author":"V Chernyak","year":"2018","unstructured":"Chernyak V, Fowler KJ, Kamaya A, Kielar AZ, Elsayes KM, Bashir MR, et al. Liver Imaging Reporting and Data System (LI-RADS) Version 2018: imaging of hepatocellular carcinoma in at-risk patients. Radiology. 2018;289(3):816\u201330. https:\/\/doi.org\/10.1148\/radiol.2018181494.","journal-title":"Radiology"},{"issue":"5","key":"7919_CR5","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1002\/hep.31819","volume":"74","author":"R Salem","year":"2021","unstructured":"Salem R, Johnson GE, Kim E, Riaz A, Bishay V, Boucher E, et al. Yttrium-90 radioembolization for the treatment of solitary, unresectable HCC: the LEGACY study. Hepatology. 2021;74(5):2342\u201352. https:\/\/doi.org\/10.1002\/hep.31819.","journal-title":"Hepatology"},{"issue":"6","key":"7919_CR6","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1053\/j.gastro.2016.08.029","volume":"151","author":"R Salem","year":"2016","unstructured":"Salem R, Gordon AC, Mouli S, Hickey R, Kallini J, Gabr A, et al. Y90 radioembolization significantly prolongs time to progression compared with chemoembolization in patients with hepatocellular carcinoma. Gastroenterology. 2016;151(6):1155-1163.e2. https:\/\/doi.org\/10.1053\/j.gastro.2016.08.029.","journal-title":"Gastroenterology"},{"issue":"3","key":"7919_CR7","doi-asserted-by":"publisher","first-page":"768","DOI":"10.2214\/AJR.06.0706","volume":"188","author":"AL Keppke","year":"2007","unstructured":"Keppke AL, Salem R, Reddy D, Huang J, Jin J, Larson AC, et al. Imaging of hepatocellular carcinoma after treatment with yttrium-90 microspheres. AJR Am J Roentgenol. 2007;188(3):768\u201375. https:\/\/doi.org\/10.2214\/AJR.06.0706.","journal-title":"AJR Am J Roentgenol"},{"key":"7919_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2020.109351","volume":"133","author":"MJ King","year":"2020","unstructured":"King MJ, Tong A, Dane B, Huang C, Zhan C, Shanbhogue K. Response assessment of hepatocellular carcinoma treated with yttrium-90 radioembolization: inter-reader variability, comparison with 3D quantitative approach, and role in the prediction of clinical outcomes. Eur J Radiol. 2020;133:109351. https:\/\/doi.org\/10.1016\/j.ejrad.2020.109351.","journal-title":"Eur J Radiol"},{"issue":"2","key":"7919_CR9","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.232408","volume":"313","author":"A Aslam","year":"2024","unstructured":"Aslam A, Chernyak V, Tang A, Miller FH, Bashir M, Do R, et al. CT\/MRI LI-RADS 2024 update: treatment response assessment. Radiology. 2024;313(2):e232408. https:\/\/doi.org\/10.1148\/radiol.232408.","journal-title":"Radiology"},{"issue":"2","key":"7919_CR10","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.apsb.2021.09.019","volume":"12","author":"D Du","year":"2022","unstructured":"Du D, Liu C, Qin M, Zhang X, Xi T, Yuan S, et al. Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma. Acta Pharm Sin B. 2022;12(2):558\u201380. https:\/\/doi.org\/10.1016\/j.apsb.2021.09.019.","journal-title":"Acta Pharm Sin B"},{"issue":"3","key":"7919_CR11","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41(3):374\u2013403. https:\/\/doi.org\/10.1016\/j.ccell.2023.02.016.","journal-title":"Cancer Cell"},{"issue":"10","key":"7919_CR12","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1038\/s41423-025-01308-4","volume":"22","author":"D Seyhan","year":"2025","unstructured":"Seyhan D, Allaire M, Fu Y, Conti F, Wang XW, Gao B, et al. Immune microenvironment in hepatocellular carcinoma: from pathogenesis to immunotherapy. Cell Mol Immunol. 2025;22(10):1132\u201358. https:\/\/doi.org\/10.1038\/s41423-025-01308-4.","journal-title":"Cell Mol Immunol"},{"issue":"9","key":"7919_CR13","doi-asserted-by":"publisher","first-page":"6268","DOI":"10.21037\/qims-22-1420","volume":"13","author":"Y Yao","year":"2023","unstructured":"Yao Y, Civelek AC, Li XF. The application of (18)F-FDG PET\/CT imaging for human hepatocellular carcinoma: a narrative review. Quant Imaging Med Surg. 2023;13(9):6268\u201379. https:\/\/doi.org\/10.21037\/qims-22-1420.","journal-title":"Quant Imaging Med Surg"},{"issue":"4","key":"7919_CR14","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/ijc.32193","volume":"146","author":"M Nurmik","year":"2020","unstructured":"Nurmik M, Ullmann P, Rodriguez F, Haan S, Letellier E. In search of definitions: cancer-associated fibroblasts and their markers. Int J Cancer. 2020;146(4):895\u2013905. https:\/\/doi.org\/10.1002\/ijc.32193.","journal-title":"Int J Cancer"},{"key":"7919_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114504","volume":"189","author":"R Rimal","year":"2022","unstructured":"Rimal R, Desai P, Daware R, Hosseinnejad A, Prakash J, Lammers T, et al. Cancer-associated fibroblasts: origin, function, imaging, and therapeutic targeting. Adv Drug Deliv Rev. 2022;189:114504. https:\/\/doi.org\/10.1016\/j.addr.2022.114504.","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"7919_CR16","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.7150\/thno.69475","volume":"12","author":"L Zhao","year":"2022","unstructured":"Zhao L, Chen J, Pang Y, Fu K, Shang Q, Wu H, et al. Fibroblast activation protein-based theranostics in cancer research: a state-of-the-art review. Theranostics. 2022;12(4):1557\u201369. https:\/\/doi.org\/10.7150\/thno.69475.","journal-title":"Theranostics"},{"issue":"5","key":"7919_CR17","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1053\/j.semnuclmed.2025.07.001","volume":"55","author":"E Novruzov","year":"2025","unstructured":"Novruzov E, Mamlins E, Mori Y, Cardinale J, Giesel FL. The clinical impact of FAPI PET imaging: HCC, CCC, CUP & peritoneal carcinoma. Semin Nucl Med. 2025;55(5):724\u201333. https:\/\/doi.org\/10.1053\/j.semnuclmed.2025.07.001.","journal-title":"Semin Nucl Med"},{"issue":"6","key":"7919_CR18","doi-asserted-by":"publisher","first-page":"3862","DOI":"10.1007\/s00259-025-07717-x","volume":"53","author":"H Gong","year":"2026","unstructured":"Gong H, Cheng Y, Li Q, Liu Y, Shang J, Li Y, et al. The predictive value of (18)F-FAPI PET\/CT and voxel-based tumor absorbed dose for the response and clinical outcome of unresectable hepatocellular carcinoma patients treated with Yttrium-90 resin microsphere selective internal radiation therapy. Eur J Nucl Med Mol Imaging. 2026;53(6):3862\u201376. https:\/\/doi.org\/10.1007\/s00259-025-07717-x","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"7919_CR19","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.2967\/jnumed.123.265712","volume":"64","author":"M Wu","year":"2023","unstructured":"Wu M, Wang Y, Yang Q, Wang X, Yang X, Xing H, et al. Comparison of Baseline (68)Ga-FAPI and (18)F-FDG PET\/CT for Prediction of Response and Clinical Outcome in Patients with Unresectable Hepatocellular Carcinoma Treated with PD-1 Inhibitor and Lenvatinib. J Nucl Med. 2023;64(10):1532\u20139. https:\/\/doi.org\/10.2967\/jnumed.123.265712.","journal-title":"J Nucl Med"},{"issue":"6","key":"7919_CR20","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1007\/s00259-024-07062-5","volume":"52","author":"D Zhu","year":"2025","unstructured":"Zhu D, Song S, Zou S, Kuang D, Wang D, Min X, et al. Assessment of viable tumours by [(68)Ga]Ga-FAPI-04 PET\/CT after local regional treatment in patients with hepatocellular carcinoma. Eur J Nucl Med Mol Imaging. 2025;52(6):2132\u201344. https:\/\/doi.org\/10.1007\/s00259-024-07062-5.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"7919_CR21","doi-asserted-by":"publisher","first-page":"3951","DOI":"10.1007\/s00259-025-07273-4","volume":"52","author":"J Liang","year":"2025","unstructured":"Liang J, Weng S, Zhang J, Jiang S, Li W, Li S, et al. Diagnostic performance of [(18)F]FAPI-04 PET\/CT in suspected recurrent hepatocellular carcinoma: prospective comparison with contrast-enhanced CT\/MRI. Eur J Nucl Med Mol Imaging. 2025;52(11):3951\u201362. https:\/\/doi.org\/10.1007\/s00259-025-07273-4.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7919_CR22","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.125.271317","author":"L Li","year":"2026","unstructured":"Li L, Ding H, Chen L, Zheng W, Zhang Y, Chen Y. Initial results and clinical experiences of [(177)Lu]Lu-FAP-2286 for pleural metastases: A single-center retrospective study. J Nucl Med. 2026. https:\/\/doi.org\/10.2967\/jnumed.125.271317.","journal-title":"J Nucl Med"},{"issue":"3","key":"7919_CR23","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s00259-025-07597-1","volume":"53","author":"NA Selcuk","year":"2026","unstructured":"Selcuk NA, Beydagi G, Akcay K, Gormez A, Toklu T, Kabasakal L. The role of [\u2076\u2078Ga]Ga-FAP-2286 PET\/CT in the evaluation of treatment response in gastrointestinal system malignancies. Eur J Nucl Med Mol Imaging. 2026;53(3):1491\u20137. https:\/\/doi.org\/10.1007\/s00259-025-07597-1.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"7919_CR24","doi-asserted-by":"publisher","first-page":"7349","DOI":"10.1007\/s00330-025-11659-1","volume":"35","author":"H Wei","year":"2025","unstructured":"Wei H, Jiang H, Yoo J, Kim JH, Kang HJ, Wu Y, et al. Temporal evolution of the LI-RADS radiation treatment response assessment on multiphase CT\/MRI in patients undergoing selective internal radiation therapy for hepatocellular carcinoma. Eur Radiol. 2025;35(11):7349\u201362. https:\/\/doi.org\/10.1007\/s00330-025-11659-1.","journal-title":"Eur Radiol"},{"issue":"2","key":"7919_CR25","doi-asserted-by":"publisher","first-page":"212","DOI":"10.2967\/jnumed.121.262134","volume":"63","author":"X Jin","year":"2022","unstructured":"Jin X, Wei M, Wang S, Wang G, Lai Y, Shi Y, et al. Detecting Fibroblast Activation Proteins in Lymphoma Using (68)Ga-FAPI PET\/CT. J Nucl Med. 2022;63(2):212\u20137. https:\/\/doi.org\/10.2967\/jnumed.121.262134.","journal-title":"J Nucl Med"},{"issue":"1","key":"7919_CR26","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.25.32745","volume":"225","author":"SH Chiu","year":"2025","unstructured":"Chiu SH, Kesselman A, Yoon L, Kamaya A, Tse JR. LI-RADS CT\/MRI radiation treatment response assessment Version 2024: category redistribution and short-term outcomes in patients undergoing (90)Y radioembolization for HCC. AJR Am J Roentgenol. 2025;225(1):e2532745. https:\/\/doi.org\/10.2214\/AJR.25.32745.","journal-title":"AJR Am J Roentgenol"},{"issue":"12","key":"7919_CR27","doi-asserted-by":"publisher","first-page":"7549","DOI":"10.1007\/s00330-025-11730-x","volume":"35","author":"H Kim","year":"2025","unstructured":"Kim H, Kim B, Son SH, Jang JW, Sung PS, Choi JI, et al. Evaluation of the LI-RADS radiation treatment response assessment v2024 in comparison with the modified RECIST. Eur Radiol. 2025;35(12):7549\u201359. https:\/\/doi.org\/10.1007\/s00330-025-11730-x.","journal-title":"Eur Radiol"},{"issue":"9","key":"7919_CR28","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1007\/s11604-025-01785-7","volume":"43","author":"J Shin","year":"2025","unstructured":"Shin J, Lee S, Yoon JK, Gu K, Baek SY, Hyun DH, et al. Application of LI-RADS CT\/MRI Radiation Treatment Response Assessment Version 2024: a study after transarterial radioembolization for hepatocellular carcinoma. Jpn J Radiol. 2025;43(9):1498\u2013508. https:\/\/doi.org\/10.1007\/s11604-025-01785-7.","journal-title":"Jpn J Radiol"},{"issue":"10","key":"7919_CR29","doi-asserted-by":"publisher","first-page":"5297","DOI":"10.1007\/s11010-025-05327-7","volume":"480","author":"W Liu","year":"2025","unstructured":"Liu W, Zou H, Wei J, Dong L, Hou W. Piezo1: the potential novel target for radiation-induced liver fibrosis by regulating FAP\u2009+\u2009fibroblasts. Mol Cell Biochem. 2025;480(10):5297\u2013308. https:\/\/doi.org\/10.1007\/s11010-025-05327-7.","journal-title":"Mol Cell Biochem"},{"key":"7919_CR30","doi-asserted-by":"publisher","unstructured":"Filippi L, Bagni O, Notarianni E, Saltarelli A, Ambrogi C, Schillaci O. PET\/CT with (18)F-choline or (18)F-FDG in Hepatocellular Carcinoma Submitted to (90)Y-TARE: A Real-World Study. Biomedicines. 2022;10(11). https:\/\/doi.org\/10.3390\/biomedicines10112996.","DOI":"10.3390\/biomedicines10112996"},{"key":"7919_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/cells9040875","author":"N Roehlen","year":"2020","unstructured":"Roehlen N, Crouchet E, Baumert TF. Liver fibrosis: mechanistic concepts and therapeutic perspectives. Cells. 2020. https:\/\/doi.org\/10.3390\/cells9040875.","journal-title":"Cells"},{"issue":"1","key":"7919_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01093-5","volume":"21","author":"I Martinez-Zubiaurre","year":"2023","unstructured":"Martinez-Zubiaurre I, Hellevik T. Cancer-associated fibroblasts in radiotherapy: bystanders or protagonists? Cell Commun Signal. 2023;21(1):108. https:\/\/doi.org\/10.1186\/s12964-023-01093-5.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"7919_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41421-024-00747-z","volume":"11","author":"Y Cheng","year":"2025","unstructured":"Cheng Y, Chen X, Feng L, Yang Z, Xiao L, Xiang B, et al. Stromal architecture and fibroblast subpopulations with opposing effects on outcomes in hepatocellular carcinoma. Cell Discov. 2025;11(1):1. https:\/\/doi.org\/10.1038\/s41421-024-00747-z.","journal-title":"Cell Discov"},{"issue":"1","key":"7919_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-025-02138-7","volume":"23","author":"L Zheng","year":"2025","unstructured":"Zheng L, Cai W, Ke Y, Hu X, Yang C, Zhang R, et al. Cancer\u2011associated fibroblasts: a pivotal regulator of tumor microenvironment in the context of radiotherapy. Cell Commun Signal. 2025;23(1):147. https:\/\/doi.org\/10.1186\/s12964-025-02138-7.","journal-title":"Cell Commun Signal"},{"issue":"11","key":"7919_CR35","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.2967\/jnumed.125.270267","volume":"66","author":"O Viering","year":"2025","unstructured":"Viering O, Brosch-Lenz J, Bundschuh RA, Scholtissek H, Enke JS, Amerein A, et al. Biodistribution and radiation dosimetry of [(68)Ga]Ga-RAYZ-8009, a Glypican 3-targeting compound for imaging of hepatocellular carcinoma. J Nucl Med. 2025;66(11):1737\u201342. https:\/\/doi.org\/10.2967\/jnumed.125.270267.","journal-title":"J Nucl Med"},{"issue":"3","key":"7919_CR36","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1158\/1078-0432.CCR-25-1856","volume":"32","author":"Z Lin","year":"2026","unstructured":"Lin Z, Li M, Pan Z, Hu W, Feng Y, Zhang X, et al. Glypican-3-targeted PET imaging for precise diagnosis of hepatocellular carcinoma: from bench to bedside. Clin Cancer Res. 2026;32(3):550\u201361. https:\/\/doi.org\/10.1158\/1078-0432.CCR-25-1856.","journal-title":"Clin Cancer Res"},{"issue":"10","key":"7919_CR37","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.2967\/jnumed.124.268147","volume":"65","author":"AJ Poot","year":"2024","unstructured":"Poot AJ, Lapa C, Weber WA, Lam M, Eiber M, Dierks A, et al. [(68)Ga]Ga-RAYZ-8009: a Glypican-3-targeted diagnostic radiopharmaceutical for hepatocellular carcinoma molecular imaging-a first-in-human case series. J Nucl Med. 2024;65(10):1597\u2013603. https:\/\/doi.org\/10.2967\/jnumed.124.268147.","journal-title":"J Nucl Med"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-07919-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-026-07919-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-07919-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:17:10Z","timestamp":1785521830000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-026-07919-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,23]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["7919"],"URL":"https:\/\/doi.org\/10.1007\/s00259-026-07919-x","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,23]]},"assertion":[{"value":"28 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This project was approved by the ethics review of the First Affiliated Hospital of Jinan University (Approval number: KY-2025-134). Written informed consent was obtained from all participants before examination.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}